Marshall Wace North America L.P. - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 85 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$43,000
-35.8%
14,3970.0%0.00%
Q2 2021$67,000
+19.6%
14,397
+49.3%
0.00%
Q1 2020$56,000
-20.0%
9,6400.0%0.00%
Q4 2019$70,0000.0%9,640
-15.7%
0.00%
Q3 2019$70,00011,4310.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 724,202$811,0000.11%
PURA VIDA INVESTMENTS, LLC 1,578,140$1,768,0000.06%
Founders Fund V Management, LLC 491,751$550,0000.04%
XTX Topco Ltd 40,618$45,0000.02%
Caption Management, LLC 725,000$813,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 236,450$265,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 51,465$58,0000.01%
Virtu Financial LLC 49,959$56,0000.00%
Caption Management, LLC 225,000$252,0000.00%
ACADIAN ASSET MANAGEMENT LLC 389,893$435,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders